Sold Out
Book Categories |
TABLE OF CONTENTS Foreword ....................................................................................................................... ix
Preface .......................................................................................................................... xi
Editors .......................................................................................................................... xiii
Contributors ................................................................................................................ xv
Reviewers ......................................................................................................................xxi
Abbreviations ............................................................................................................ xxv
List of Web Resources ............................................................................................... xxix
SECTION ONE: Historical and Social Issues ................................................................ 1
Chapter 1: History of Women’s Healthcare and Research
Rosalie Sagraves, Pharm.D., F.A.Ph.A., FCCP;
Jennifer A. McIntosh, Pharm.D., MHS .................................................................................. 3
Chapter 2: Race, Ethnic, and Religious Issues
Jeri J. Sias, Pharm.D., MPH; Mary Beth O’Connell, Pharm.D., BCPS, FASHP, FCCP;
James A. Berch, AB, MA; Imam Achmat Salie, DBA, AFK, MBA; Robert Taylor ........... 21
Chapter 3: Socioeconomics
Margaret B. Artz, Ph.D., R.Ph.; Mary E. S. Indritz, Ph.D., R.Ph., FASHP;
Kathryn E. Peek, MS, MA, Ph.D.; Joslyn W. Fisher, MD, MPH, FACP;
Barbara W. K. Yee, Ph.D. .................................................................................................... 39
Chapter 4: Psychosocial Factors
Heather E. Dillaway, Ph.D.; Catherine L. Lysack, Ph.D., OT(C) ......................................... 57
Chapter 5: Issues in Lesbian, Bisexual, and Transgender Healthcare
Wendy B. Bostwick, Ph.D., MPH; Katherine A. O’Hanlan, MD, FACOG, FACS, SGO;
Perry Silverschanz, Ph.D., MSW ........................................................................................ 73
SECTION TWO: Female Biology, Physiology, and Wellness ..................................... 85
Chapter 6: Anatomy and Physiology
Alicia B. Forinash, Pharm.D., BCPS, CCD; Evelyn S. Becker, Pharm.D., MA;
Norma J. Owens, Pharm.D., BCPS, FCCP ......................................................................... 87
Chapter 7: Sex and Gender Differences
Norma J. Owens, Pharm.D., BCPS, FCCP; Alicia B. Forinash, Pharm.D., BCPS, CCD;
Kelly L. Matson, BSN, Pharm.D. ...................................................................................... 103
Chapter 8: Health and Wellness
Kelly L. Matson, BSN, Pharm.D.; Alicia B. Forinash, Pharm.D., BCPS, CCD;
Norma J. Owens, Pharm.D., BCPS, FCCP ...................................................................... 117
Chapter 9: Medication Use and Complementary and Alternative Therapy
Mary L. Chavez, B.S.Pharm., Pharm.D., FAACP;
Leslie A. Shimp, Pharm.D., MS; Philip J. Gregory, Pharm.D. ........................................... 133
SECTION THREE: Menstrual Health .......................................................................... 149
Chapter 10: Menstrual Cycle
Desireé M. McCarthy-Keith, MD, MPH;
Alicia Armstrong, MD, MHSCR ...................................................................................... 151
Chapter 11: Menstruation Disorders
Somjate Manipalviratn, MD; Alicia Armstrong, MD, MHSCR ...................................... 161
Chapter 12: Dysmenorrhea
Devra K. Dang, Pharm.D., BCPS, CDE; Fei Wang, M.Sc., Pharm.D., BCPS, FASHP;
Karim Anton Calis, Pharm.D., MPH, FASHP, FCCP ........................................................ 181
Chapter 13: Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Teresa M. Bailey, Pharm.D., BCPS, FCCP;
Nicole S. Culhane, Pharm.D., BCPS, FCCP ..................................................................... 195
Chapter 14: Endometriosis
Andrea L. Coffee, Pharm.D., BCPS, MBA; Lazaros G. Lavasidis, MD;
Sophia N. Kalantaridou, MD, Ph.D. ................................................................................. 207
Chapter 15: Primary Ovarian Insuffi ciency
Sophia N. Kalantaridou, MD, Ph.D.; Lazaros G. Lavasidis, MD;
Karim Anton Calis, Pharm.D., MPH, FASHP, FCCP ........................................................ 225
Chapter 16: Polycystic Ovary Syndrome
Laura Marie Borgelt, Pharm.D., FCCP, BCPS;
Kai I. Cheang, Pharm.D., M.Sc., BCPS, FCCP ................................................................. 235
Chapter 17: Menopause
Fiona Jane, MBBS; Susan R. Davis, MBBS, Ph.D., FRACP ............................................... 249
SECTION FOUR: Contraceptive Methods ................................................................ 267
Chapter 18: Family Planning and Nonhormonal Contraception
Jacki S. Witt, JD, MSN, WHNP, CNM; Julie L. Strickland, MD, MPH;
Kimberly Thrasher, Pharm.D., BCPS, FCCP, CPP ........................................................... 269
Chapter 19: Hormonal Contraception
Shareen Y. El-Ibiary, Pharm.D., BCPS; Jessica L.White, Pharm.D., BCPS ....................... 289
Chapter 20: Emergency Contraception
Don Downing, R.Ph.; Deborah A. Sturpe, Pharm.D., BCPS ......................................... 311
SECTION FIVE: Preconception, Pregnancy, and Postpartum Care ........................ 325
Chapter 21: Pregnancy Planning
Jennifer J. Lee, Pharm.D., BCPS, CDE; Tracy E. Thomason, Pharm.D. .......................... 327
Chapter 22: Infertility
Jaou-Chen Huang, MD, FACOG; Nancy D. Ordonez, Pharm.D., BCPS ...................... 339
Chapter 23: Drug Principles in Pregnancy and Lactation
Pamela D. Berens, MD; Thomas W. Hale, R.Ph., Ph.D. ................................................. 355
Chapter 24: Conditions Associated with Pregnancy
Patricia Rozek Wigle, Pharm.D., BCPS;
Karissa Y. Kim, Pharm.D., CACP, BCPS ........................................................................... 371
Chapter 25: Pregnancy and Pre-existing Illnesses
Jeanne Hawkins VanTyle, Pharm.D., MS;
Trisha LaPointe, Pharm.D., BCPS ..................................................................................... 387
Chapter 26: High-Risk Pregnancies
Kirk D. Ramin, MD; Timothy S. Tracy, Ph.D. ................................................................... 403
Chapter 27: Prenatal Diagnosis
Tiki Bakhshi, MD; Andrea L. Coffee, Pharm.D., BCPS, MBA;
Joan M. Mastrobattista, MD ........................................................................................... 415
Chapter 28: Labor and Delivery
Carla Ann Martinez, MD; Julie J. Kelsey, Pharm.D.;
Mildred M. Ramirez, MD ................................................................................................ 425
Chapter 29: Postpartum Care
Charlie C. Kilpatrick, MD; Manju Monga, MD .............................................................. 439
SECTION SIX: Selected Conditions in Women ......................................................... 447
Chapter 30: Cardiovascular Disease
Anne L. Hume, Pharm.D., FCCP, BCPS; Lisa B. Cohen, Pharm.D., CDE ....................... 449
Chapter 31: Nutrition and Eating Disorders
Kimberly Braxton Lloyd, Pharm.D.; Connie Kraus, Pharm.D., BCPS ............................. 473
Chapter 32: Overweight and Obesity
Judy T. Chen, Pharm.D., BCPS, CDE; Amy Heck Sheehan, Pharm.D.;
Martha Stassinos, Pharm.D.;
Karim Anton Calis, Pharm.D., MPH, FASHP, FCCP ........................................................ 493
Chapter 33: Gastrointestinal Disorders
Brian A. Hemstreet, Pharm.D., BCPS;
Charmaine D. Rochester, Pharm.D., CDE, BCPS ............................................................ 511
Chapter 34: Mental Health
Tracy L. Skaer, Pharm.D., FABFE, FASCP, FASHP; Carol M. Odell, MSN, FNP .............. 533
Chapter 35: Sexual Disorders
Candace S. Brown, Pharm.D., MSN; Sandra R. Leiblum, Ph.D. ..................................... 545
Chapter 36: Substance-Use Disorders
Bethany A. DiPaula, Pharm.D., BCPP; Sneha Baxi, Pharm.D. ........................................ 563
Chapter 37: Immunity and Autoimmune Diseases
Gail Goodman Snitkoff, Ph.D.; Andrea K. Hubbard, Ph.D.; Jennie Broders, Pharm.D.;
Arthur A. Schuna, MS, FASHP ........................................................................................ 579
Chapter 38: Sexually Transmitted and Infectious Diseases
Lisa D. Inge, Pharm.D., BCPS, AAHIVE; Kimberley C. Brown, Pharm.D., AAHIVE;
Raymond Cha, Pharm.D. ................................................................................................. 597
Chapter 39: Genitourinary Disorders
Susan K. Bowles, B.Sc.Pharm., Pharm.D., M.Sc. ............................................................. 623
Chapter 40: Bone and Joint Disorders
Mary Beth O’Connell, Pharm.D., BCPS; Nima M. Patel, Pharm.D., BCPS;
Sharon L. Hame, MD ....................................................................................................... 641
Chapter 41: Neurological Disorders
Sarah L. Johnson, Pharm.D.; Jacquelyn L. Bainbridge, B.S.Pharm., Pharm.D.;
Melody Ryan, Pharm.D., MPH; Edna Elise Moore, MSN, ARNP, WHNP-C;
Dennis Parker Jr., Pharm.D.; Baochau Nguyen, Pharm.D.;
Debbie Rodriquez, RN, Pharm.D. ................................................................................... 657
Chapter 42: Dermatologic Conditions
Neha Shah, MD; Lee E. West, B.S.Pharm.; Kyle Anderson, MD;
Bethanee J. Schlosser, MD, Ph.D.; Ginat W. Mirowski, DMD, MD;
Dennis P. West, Ph.D., FCCP, CIP .................................................................................... 687
SECTION SEVEN: Cancer in Women ......................................................................... 701
Chapter 43: Breast Cancer
Chad Barnett, Pharm.D., BCOP; Janet L. Espirito, Pharm.D., BCOP ............................. 703
Chapter 44: Endometrial Cancer
Claire M. Mach, Pharm.D.; Lynn Cloutier, RN, MSN, ACNP, AOCN ............................ 721
Chapter 45: Ovarian Cancer
Marisa Navo Mendoza, Pharm.D.; Jubilee Brown, MD ................................................ 735
Chapter 46: Cervical Cancer
Judith Ann Smith, Pharm.D., BCOP, FCCP, FISOPP ........................................................ 749
Chapter 47: Management of Treatment Complications
Claire Saadeh, Pharm.D., BCOP; Makala Pace, Pharm.D., BCOP;
Sheetal Sheth, Pharm.D., BCOP ...................................................................................... 761
SECTION EIGHT: Ethical Issues in Women’s Healthcare .......................................... 775
Chapter 48: Ethics and Ethical Dilemmas
Amy M. Haddad, Ph.D. ................................................................................................... 777
Chapter 49: Ethical Decision Making
Jean Abbott, MD, MH; Peter V. Tortorice, Pharm.D., BCOP;
Jacyln Michelle Graham, Pharm.D. ................................................................................. 789
Glossary ..................................................................................................................... 803
Laboratory Reference Values .................................................................................... 815
Index .......................................................................................................................... 818
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionWomen's Health across the Lifespan: A Pharmacotherapeutic Approach
X
This Item is in Your InventoryWomen's Health across the Lifespan: A Pharmacotherapeutic Approach
X
You must be logged in to review the productsX
X
X
Add Women's Health across the Lifespan: A Pharmacotherapeutic Approach, Introducing the first pharmacotherapy reference to focus on women's health. Just as diseases affect women and men differently, so do drugs. Yet there has never been a comprehensive pharmacotherapy reference focused on women and women's health until, Women's Health across the Lifespan: A Pharmacotherapeutic Approach to the inventory that you are selling on WonderClubX
X
Add Women's Health across the Lifespan: A Pharmacotherapeutic Approach, Introducing the first pharmacotherapy reference to focus on women's health. Just as diseases affect women and men differently, so do drugs. Yet there has never been a comprehensive pharmacotherapy reference focused on women and women's health until, Women's Health across the Lifespan: A Pharmacotherapeutic Approach to your collection on WonderClub |